Mayo Clinic strategic transactions and intellectual property have been instrumental to the creation and success of numerous collaborations, exclusive agreements, start-up companies, business ventures and equity investments.
Below is a small sampling.
Impact stories
Oncolytic virus therapies
Sodium-iodide symporter reporter gene imaging system
Read case study
Phage therapy treatment
Using viruses to target and kill specific bacteria
Read case study
Evolving vaccine efforts
Single-cycle adenovirus vaccine platform
Read case study
Cancer screening revolution
FDA-approved noninvasive colorectal screening
Read case study
Remote ECG patient monitoring
Mayo Clinic IP paves way for FDA-cleared remote heart monitoring device
Read case study
Magnetic Resonance Elastography
Revolutionary imaging tool for diagnosing liver fibrosis
Read case study
Innovation Spotlight
Complex disease requires new, innovative approaches to medicine. In response, Mayo Clinic is actively developing transformative processes that can bring novel and better cures to patients.
With a distinct focus on cell therapy products and viral vectors, investment in these processes and products is needed to produce cures for patients at greater speed and scale.
Content displayed is subject to change.